220 related articles for article (PubMed ID: 30226466)
1. Genetic predisposition to uterine leiomyoma is determined by loci for genitourinary development and genome stability.
Välimäki N; Kuisma H; Pasanen A; Heikinheimo O; Sjöberg J; Bützow R; Sarvilinna N; Heinonen HR; Tolvanen J; Bramante S; Tanskanen T; Auvinen J; Uimari O; Alkodsi A; Lehtonen R; Kaasinen E; Palin K; Aaltonen LA
Elife; 2018 Sep; 7():. PubMed ID: 30226466
[TBL] [Abstract][Full Text] [Related]
2. Highly heterogeneous genomic landscape of uterine leiomyomas by whole exome sequencing and genome-wide arrays.
Yatsenko SA; Mittal P; Wood-Trageser MA; Jones MW; Surti U; Edwards RP; Sood AK; Rajkovic A
Fertil Steril; 2017 Feb; 107(2):457-466.e9. PubMed ID: 27889101
[TBL] [Abstract][Full Text] [Related]
3. Variants associating with uterine leiomyoma highlight genetic background shared by various cancers and hormone-related traits.
Rafnar T; Gunnarsson B; Stefansson OA; Sulem P; Ingason A; Frigge ML; Stefansdottir L; Sigurdsson JK; Tragante V; Steinthorsdottir V; Styrkarsdottir U; Stacey SN; Gudmundsson J; Arnadottir GA; Oddsson A; Zink F; Halldorsson G; Sveinbjornsson G; Kristjansson RP; Davidsson OB; Salvarsdottir A; Thoroddsen A; Helgadottir EA; Kristjansdottir K; Ingthorsson O; Gudmundsson V; Geirsson RT; Arnadottir R; Gudbjartsson DF; Masson G; Asselbergs FW; Jonasson JG; Olafsson K; Thorsteinsdottir U; Halldorsson BV; Thorleifsson G; Stefansson K
Nat Commun; 2018 Sep; 9(1):3636. PubMed ID: 30194396
[TBL] [Abstract][Full Text] [Related]
4. Replication of GWAS loci revealed the moderate effect of TNRC6B locus on susceptibility of Saudi women to develop uterine leiomyomas.
Bondagji NS; Morad FA; Al-Nefaei AA; Khan IA; Elango R; Abdullah LS; M Al-Mansouri N; Sabir J; Banaganapalli B; Edris S; Shaik NA
J Obstet Gynaecol Res; 2017 Feb; 43(2):330-338. PubMed ID: 27987337
[TBL] [Abstract][Full Text] [Related]
5. Catechol-O-methyltransferase Val158Met polymorphism is associated with increased risk of multiple uterine leiomyomas either positive or negative for
Dzhemlikhanova LK; Efimova OA; Osinovskaya NS; Parfenyev SE; Niauri DA; Sultanov IY; Malysheva OV; Pendina AA; Shved NY; Ivashchenko TE; Yarmolinskaya MI; Kakhiani MI; Gorovaya EA; Tkachenko AN; Baranov VS
J Clin Pathol; 2017 Mar; 70(3):233-236. PubMed ID: 27491313
[TBL] [Abstract][Full Text] [Related]
6. Epidemiological and genetic clues for molecular mechanisms involved in uterine leiomyoma development and growth.
Commandeur AE; Styer AK; Teixeira JM
Hum Reprod Update; 2015; 21(5):593-615. PubMed ID: 26141720
[TBL] [Abstract][Full Text] [Related]
7. Missense mutations in exon 2 of the MED12 gene are involved in IGF-2 overexpression in uterine leiomyoma.
Di Tommaso S; Tinelli A; Malvasi A; Massari S
Mol Hum Reprod; 2014 Oct; 20(10):1009-15. PubMed ID: 25015674
[TBL] [Abstract][Full Text] [Related]
8. Identification of a novel uterine leiomyoma GWAS locus in a Japanese population.
Sakai K; Tanikawa C; Hirasawa A; Chiyoda T; Yamagami W; Kataoka F; Susumu N; Terao C; Kamatani Y; Takahashi A; Momozawa Y; Hirata M; Kubo M; Fuse N; Takai-Igarashi T; Shimizu A; Fukushima A; Kadota A; Arisawa K; Ikezaki H; Wakai K; Yamaji T; Sawada N; Iwasaki M; Tsugane S; Aoki D; Matsuda K
Sci Rep; 2020 Jan; 10(1):1197. PubMed ID: 31988393
[TBL] [Abstract][Full Text] [Related]
9. Frequency and Spectrum of MED12 Exon 2 Mutations in Multiple Versus Solitary Uterine Leiomyomas From Russian Patients.
Osinovskaya NS; Malysheva OV; Shved NY; Ivashchenko TE; Sultanov IY; Efimova OA; Yarmolinskaya MI; Bezhenar VF; Baranov VS
Int J Gynecol Pathol; 2016 Nov; 35(6):509-515. PubMed ID: 26630226
[TBL] [Abstract][Full Text] [Related]
10. Genetic Association Studies in Uterine Fibroids: Risk Alleles Presage the Path to Personalized Therapies.
Gallagher CS; Morton CC
Semin Reprod Med; 2016 Jul; 34(4):235-41. PubMed ID: 27513025
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting the loss of MED12-mutated leiomyoma cells during in vitro growth.
Bloch J; Holzmann C; Koczan D; Helmke BM; Bullerdiek J
Oncotarget; 2017 May; 8(21):34762-34772. PubMed ID: 28410233
[TBL] [Abstract][Full Text] [Related]
12. Vitamin D as an effective treatment in human uterine leiomyomas independent of mediator complex subunit 12 mutation.
Corachán A; Trejo MG; Carbajo-García MC; Monleón J; Escrig J; Faus A; Pellicer A; Cervelló I; Ferrero H
Fertil Steril; 2021 Feb; 115(2):512-521. PubMed ID: 33036796
[TBL] [Abstract][Full Text] [Related]
13. Characterization of uterine leiomyomas by whole-genome sequencing.
Mehine M; Kaasinen E; Mäkinen N; Katainen R; Kämpjärvi K; Pitkänen E; Heinonen HR; Bützow R; Kilpivaara O; Kuosmanen A; Ristolainen H; Gentile M; Sjöberg J; Vahteristo P; Aaltonen LA
N Engl J Med; 2013 Jul; 369(1):43-53. PubMed ID: 23738515
[TBL] [Abstract][Full Text] [Related]
14. Genomics of uterine leiomyomas: insights from high-throughput sequencing.
Mehine M; Mäkinen N; Heinonen HR; Aaltonen LA; Vahteristo P
Fertil Steril; 2014 Sep; 102(3):621-9. PubMed ID: 25106763
[TBL] [Abstract][Full Text] [Related]
15. MED12 mutation frequency in unselected sporadic uterine leiomyomas.
Heinonen HR; Sarvilinna NS; Sjöberg J; Kämpjärvi K; Pitkänen E; Vahteristo P; Mäkinen N; Aaltonen LA
Fertil Steril; 2014 Oct; 102(4):1137-42. PubMed ID: 25108465
[TBL] [Abstract][Full Text] [Related]
16. Inherited mutations affecting the SRCAP complex are central in moderate-penetrance predisposition to uterine leiomyomas.
Välimäki N; Jokinen V; Cajuso T; Kuisma H; Taira A; Dagnaud O; Ilves S; Kaukomaa J; Pasanen A; Palin K; Heikinheimo O; Bützow R; Aaltonen LA; Karhu A
Am J Hum Genet; 2023 Mar; 110(3):460-474. PubMed ID: 36773604
[TBL] [Abstract][Full Text] [Related]
17. A comprehensive genome-wide cross-trait analysis of sexual factors and uterine leiomyoma.
Wu X; Xiao C; Rasooly D; Zhao X; Morton CC; Jiang X; Gallagher CS
PLoS Genet; 2024 May; 20(5):e1011268. PubMed ID: 38701081
[TBL] [Abstract][Full Text] [Related]
18. Clonally related uterine leiomyomas are common and display branched tumor evolution.
Mehine M; Heinonen HR; Sarvilinna N; Pitkänen E; Mäkinen N; Katainen R; Tuupanen S; Bützow R; Sjöberg J; Aaltonen LA
Hum Mol Genet; 2015 Aug; 24(15):4407-16. PubMed ID: 25964426
[TBL] [Abstract][Full Text] [Related]
19. MicroRNAs involved in the HMGA2 deregulation and its co-occurrence with MED12 mutation in uterine leiomyoma.
Mello JBH; Barros-Filho MC; Abreu FB; Cirilo PDR; Domingues MAC; Pontes A; Rogatto SR
Mol Hum Reprod; 2018 Nov; 24(11):556-563. PubMed ID: 30376129
[TBL] [Abstract][Full Text] [Related]
20. Exomic landscape of MED12 mutation-negative and -positive uterine leiomyomas.
Mäkinen N; Vahteristo P; Bützow R; Sjöberg J; Aaltonen LA
Int J Cancer; 2014 Feb; 134(4):1008-12. PubMed ID: 23913526
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
